Administration Method of Adjuvant Tegafur-Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study.

Taishi HataKiyotaka HagiharaAnna TsutsuiHiroki AkamatsuMasayuki OhueTatsushi ShingaiMitsuyoshi TeiMasakazu IkenagaHo Min KimHideki OsawaHiroyoshi TakemotoKen KonishiMamoru UemuraChu MatsudaTsunekazu MizushimaKohei MurataYuko OhnoYuichiro DokiHidetoshi Eguchi

Published in: The oncologist (2021)

Group B outcomes were not inferior to group A outcomes, and adverse events did not increase.

Keyphrases

phase iii
open label
clinical trial
early stage
lymph node
double blind
randomized controlled trial
adipose tissue
insulin resistance